Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Oral Sessions 10:3O - 12:00oo

Tuesday luly 9

lm.v 0 Wft %. - -- - -1 0 - -1 11

A04 IViral Entry & Chemokines (II)
Oral Abstract Session
Venue: Hall 1:1
Date: Tuesday, July 09, 2002
Time: 10:30 - 12:00
Chairs: Jeremy Landau, United States
Benito Regueiro, Spain

11:oo00 TuOrB1142

Intermittent use of triple combination
therapy and not non-nucleoside reverse
transcriptase inhibitor use is predictive
of mortality among persons initiating
antiretroviral therapy in a populationbased setting
RS Hoqgg, K V Heath, B Yip,
J S G Montaner (Canada)

10:30 TuOrA146
o10:45 TuOrA1135
11:oo TuOrA1138
11:15 TuOrA1139

Chemokines: A natural barrier against
HIV?
Fernando Arenzana (France)
Interleukin-7 accelerates HIV X4
replication by inducing the production of
B-chemokines, downregulation of CCR5
and upregulation of CXCR4
A Llano I Barretina, A Gutierrez,
B Clotet, j Este (Spain)
Reversion of HIV-1 with mutations in the
tryptophan-rich region of gp41
Q Yu, E Hunter (United States)
Human urogenital epithelial cells capture
HIV-1 and transmit the virus to CD4+
cells? Implications to mechanisms of
sexual transmission
Z Wu, VZacropoulos, Z Chen, D Phillips
(United States)

Tuesday

11:30 TuOrAl137 SDF-1 production by dendritic cells and
regulation of CXCR4 in T lymphocytes
M Bermeio1, J Martin Serrano', Alonso',
j L de Pablos', C Gamallo', FArenzana2,
J AlcamiP (Spain; 2France)
11:45 TuOrA1136 Innate immunity in HIV infection:
importance of the interferon-producing
cells
Jay Leyy (United States)
BOS When Should you Start ARV Therapy?
Oral Abstract Session
Venue: Hall 2:1
Date: Tuesday, July 09, 2002
Time: 10:30-12:00
Chairs: Michel Kazatchkine, France
Ferran Segura, Spain

11:15 TuOrB1143 Lead-time adjustment in cohort studies
evaluating when to initiate therapy
S R Cole, R Li, K Anastos, R Detels,
M Young, J P Phair, A Mufioz
(United States)
11:30 TuOrB147 Starting therapy in developing countries
Papa Sali Sow (Senegal)
11:45 TuOrB148 When to start ARV therapy: where are we
now?
Patrick Yeni (France)
B06 ]Mother to Child Transmission (MTCT)
Oral Abstract Session
Venue: Hall Verdi
Date: Tuesday, July o9, 2002
Time: lo:3o - 12:oo00
Chairs: Chewe Luo, UNICEF
Antonio Mur, Spain
10:3o TuOrB1174 Effect of Nevirapine (NVP) for perinatal
HIV prevention appears strong among
women with advanced disease:
subgroup analyses of HIVNET 012
C Nakabiito', LA Guay', P Musoke',
T Fleming2, J B Jackson', F Mmiro',
M G Fowler2, A Mwatha'
(Uganda; 2United States)
10:45 TuOrB1175 Successful nevirapine-based prevention
of mother-to-child transmission in
Southern Ukraine
J B W van der Meer K Lezhentsev,
A Younis, R Malyuta (Ukraine)
11:oo TuOrB1176 Uptake of interventions to reduce
mother-to-child HIV transmission:
nevirapine and exclusive breastfeeding
in the Zambia exclusive breastfeeding
study (ZEBS)
L Kuhn', P Kasonde2, C Vwalika2,
E Shutes', M Sinkala2, C Kankasa2,
G Aldrovandi', E Piwoz', D M Theao'
(United States; 2Zambia)
11:15 TuOrB1177 Breastfeeding and late postnatal
transmission of HIV-i: an individual
patient data meta-analysis (Breastfeeding
and HIV International Transmission Study)
J S Read', M L NewelP2, F Dabis3, V Leroy3
('United States; 2United Kingdom;
3France)

10:30 TuOrB114o

Prognosis of HIV-1 infected drug naive
patients starting potent antiretroviral
therapy. ART Cohort Collaboration
G Chene', M May2, D Costagliola',
A d'Arminio Monforte3, C junghans2,
F de Wolf4, J D Lundgren5, G Fusco6,
V MillerZ, C Leport', F Dabis',
R S Hogg8, A N Phillips2, Mj Gill8,
B Salzberger7, J A C Sterne, M Egger2
(France; 2United Kingdom; 3ltaly;
4The Netherlands; 5Denmark;
6United States; 7Germany; 8Canada)
Low CD4 count predicts less durable
virologic response to highly active
antiretroviral therapy (HAART) in naive
patients
j T Brooks DL Hanson, AD
McNaghten, D L Swerdlow, The Adult and
Adolescent Spectrum of HIV Disease
(ASD) Working Group (United States)

o10:45 TuOrB1141

11:30 TuOrB1178
11:45 TuOrB149

Effectiveness of the prevention of
mother-to-child transmission program
and the influence of feeding options in
an urban hospital in Kampala, Uganda
M Maqoni, P Kituuka', P Okong',
L Bassani', E Germinario2, M Massella2,
M Giuliano2 (Uganda; 2taly)
Title to be announced
Chewe Luo (UNICEF)

76 Final Program